156 related articles for article (PubMed ID: 34688637)
1. A review on the role of different ephrins in glioma.
Zhu B; Li Y; Mao X
Eur J Pharmacol; 2022 Feb; 917():174588. PubMed ID: 34688637
[TBL] [Abstract][Full Text] [Related]
2. Ephrin-B3 ligand promotes glioma invasion through activation of Rac1.
Nakada M; Drake KL; Nakada S; Niska JA; Berens ME
Cancer Res; 2006 Sep; 66(17):8492-500. PubMed ID: 16951161
[TBL] [Abstract][Full Text] [Related]
3. Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer.
Efazat G; Novak M; Kaminskyy VO; De Petris L; Kanter L; Juntti T; Bergman P; Zhivotovsky B; Lewensohn R; Hååg P; Viktorsson K
Oncotarget; 2016 Sep; 7(37):60332-60347. PubMed ID: 27533087
[TBL] [Abstract][Full Text] [Related]
4. Ephrin-As, Eph receptors and integrin α3 interact and colocalise at membrane protrusions of U251MG glioblastoma cells.
Makarov A; Ylivinkka I; Nyman TA; Hyytiäinen M; Keski-Oja J
Cell Biol Int; 2013 Oct; 37(10):1080-8. PubMed ID: 23686814
[TBL] [Abstract][Full Text] [Related]
5. Sizes of interface residues account for cross-class binding affinity patterns in Eph receptor-ephrin families.
Guo FY; Lesk AM
Proteins; 2014 Mar; 82(3):349-53. PubMed ID: 24105818
[TBL] [Abstract][Full Text] [Related]
6. Expression of ephrin-A ligands and EphA receptors in the developing mouse tooth and its supporting tissues.
Luukko K; Løes S; Kvinnsland IH; Kettunen P
Cell Tissue Res; 2005 Jan; 319(1):143-52. PubMed ID: 15517401
[TBL] [Abstract][Full Text] [Related]
7. Role of Eph/ephrin tyrosine kinase in malignant glioma.
Nakada M; Hayashi Y; Hamada J
Neuro Oncol; 2011 Nov; 13(11):1163-70. PubMed ID: 21856686
[TBL] [Abstract][Full Text] [Related]
8. Stem-like Cells from Invasive Breast Carcinoma Cell Line MDA-MB-231 Express a Distinct Set of Eph Receptors and Ephrin Ligands.
Lucero M; Thind J; Sandoval J; Senaati S; Jimenez B; Kandpal RP
Cancer Genomics Proteomics; 2020; 17(6):729-738. PubMed ID: 33099474
[TBL] [Abstract][Full Text] [Related]
9. Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK.
Liu DP; Wang Y; Koeffler HP; Xie D
Int J Oncol; 2007 Apr; 30(4):865-71. PubMed ID: 17332925
[TBL] [Abstract][Full Text] [Related]
10. Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene.
Sukka-Ganesh B; Mohammed KA; Kaye F; Goldberg EP; Nasreen N
BMC Cancer; 2012 Jul; 12():309. PubMed ID: 22824143
[TBL] [Abstract][Full Text] [Related]
11. Expression of Eph receptors and their ligands, ephrins, during lipopolysaccharide fever in rats.
Ivanov AI; Steiner AA; Scheck AC; Romanovsky AA
Physiol Genomics; 2005 Apr; 21(2):152-60. PubMed ID: 15671251
[TBL] [Abstract][Full Text] [Related]
12. Divergent roles for Eph and ephrin in avian cranial neural crest.
Mellott DO; Burke RD
BMC Dev Biol; 2008 May; 8():56. PubMed ID: 18495033
[TBL] [Abstract][Full Text] [Related]
13. Methylmercury alters Eph and ephrin expression during neuronal differentiation of P19 embryonal carcinoma cells.
Wilson DT; Polunas MA; Zhou R; Halladay AK; Lowndes HE; Reuhl KR
Neurotoxicology; 2005 Aug; 26(4):661-74. PubMed ID: 15990172
[TBL] [Abstract][Full Text] [Related]
14. Human dendritic cells express neuronal Eph receptor tyrosine kinases: role of EphA2 in regulating adhesion to fibronectin.
de Saint-Vis B; Bouchet C; Gautier G; Valladeau J; Caux C; Garrone P
Blood; 2003 Dec; 102(13):4431-40. PubMed ID: 12907451
[TBL] [Abstract][Full Text] [Related]
15. Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis.
Nakamoto M; Bergemann AD
Microsc Res Tech; 2002 Oct; 59(1):58-67. PubMed ID: 12242697
[TBL] [Abstract][Full Text] [Related]
16. Ephs and Ephrins in malignant gliomas.
Ferluga S; Debinski W
Growth Factors; 2014 Dec; 32(6):190-201. PubMed ID: 25418012
[TBL] [Abstract][Full Text] [Related]
17. Developmental expression of Eph and ephrin family genes in mammalian small intestine.
Islam S; Loizides AM; Fialkovich JJ; Grand RJ; Montgomery RK
Dig Dis Sci; 2010 Sep; 55(9):2478-88. PubMed ID: 20112066
[TBL] [Abstract][Full Text] [Related]
18. May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?
Psilopatis I; Karniadakis I; Danos KS; Vrettou K; Michaelidou K; Mavridis K; Agelaki S; Theocharis S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613532
[TBL] [Abstract][Full Text] [Related]
19. A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptors.
Noberini R; De SK; Zhang Z; Wu B; Raveendra-Panickar D; Chen V; Vazquez J; Qin H; Song J; Cosford ND; Pellecchia M; Pasquale EB
Chem Biol Drug Des; 2011 Oct; 78(4):667-78. PubMed ID: 21791013
[TBL] [Abstract][Full Text] [Related]
20. Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation.
Giorgio C; Hassan Mohamed I; Flammini L; Barocelli E; Incerti M; Lodola A; Tognolini M
PLoS One; 2011 Mar; 6(3):e18128. PubMed ID: 21479221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
